Differences In Test Performance Research Articles

The Effects of Cognitive Behavioral Therapy for Postcancer Fatigue on Perceived Cognitive Disabilities and Neuropsychological Test Performance

ContextAfter successful cancer treatment, a substantial number of survivors continue to experience fatigue and related concentration and memory problems. Severe fatigue after cancer treatment can be treated effectively with cognitive behavioral therapy (CBT), but it is unclear whether CBT has an effect on cognitive functioning. ObjectivesWe hypothesized that patients would report less cognitive disability after treatment with CBT for cancer-related fatigue. CBT was not expected to affect neuropsychological test performance, as it has been shown that fatigue is not associated with test performance. MethodsData were used from a randomized controlled trial in which 98 severely fatigued cancer survivors, treated at least one year previously, were assessed at baseline (T1) and six months post-baseline (T2). Patients were randomly assigned to receive CBT (n = 50) or to a waiting list (WL) control condition (n = 48). Self-reported cognitive disability was assessed by the Concentration subscale of the Checklist Individual Strength and the Alertness Behavior subscale of the Sickness Impact Profile. Neuropsychological test performance was measured by the symbol digit modalities task and two reaction time tasks. ResultsPatients who received CBT for post-cancer fatigue reported significantly less cognitive disability compared with those in the WL group. CBT also was associated with a clinically relevant reduction in concentration problems (CBT, 32% vs. WL, 2%). There were no significant differences in neuropsychological test performance between the CBT and WL groups. ConclusionCBT for post-cancer fatigue has already been shown to be an effective therapy. The present study demonstrates that CBT also may lead to a decrease in perceived cognitive disability.

CERAD test performance and cognitive impairment in Parkinson's disease

Many patients with Parkinson's disease (PD) develop mild cognitive impairment (PD-MCI) and dementia (PDD). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neurocognitive test battery was originally developed to identify early Alzheimer's disease, but it has become a widely used screening instrument also for other types of dementia. The aim of the study was to examine differences in CERAD test performances between cognitively intact and impaired PD patients. Eighty-eight PD patients participating in a rehabilitation course were studied. The Clinical Dementia Rating (CDR) was used to assess cognitive impairment. Sixty-six patients were cognitively intact and 22 had cognitive impairment (≥1 in two or more domains or a sum of boxes score of ≥3). The Finnish CERAD test battery was used to measure cognitive functions in seven different domains (language functions, verbal learning, visuospatial functions, delayed recall, memory consolidation, recognition memory, and executive functions). There were significant differences between the cognitively intact and impaired patients in six CERAD subtests (wordlist learning sum, wordlist delayed recall, constructional praxis recall, clock drawing, verbal fluency and constructional praxis copy) when controlling for covariates (disease duration, motor symptoms, age, and education). No differences were observed in memory consolidation scores. The results indicate that mild cognitive impairment in PD is related to deficits in memory, executive functions, and visuospatial functions. The memory deficit is non-amnestic and does not entail accelerated forgetting. CERAD shows promise in identifying PD patients with cognitive impairment and increased risk of dementia.

PCN36 - Cost Analysis Model Between The Cobas Braf Test And Sanger Sequencing When Treating Malignant Melanoma Based On The Presence Of V600 Mutations

Validated companion diagnostic assays permit collection of critical clinical data that leads to actionable treatment decisions and better patient outcomes. The cobas BRAF test is an FDA-approved companion diagnostic that identifies V600 mutation positive malignant melanoma to determine patient eligibility for treatment with vemurafenib. Sanger sequencing is also a validated, lab developed test that provides similar information for the gene encoding the BRAF protein. Test performance differences can have an impact on patient outcomes and overall cost of testing and treatment. Based on assay performance data for both tests, generated during the phase 2 BRIM-2 (N=132), BRIM-2/3 (N=433) and phase 3 BRIM-3 (N=449) studies, an integrated drug-diagnostic budget impact model was developed from a third-party payer perspective assuming a 6-month treatment period. Cost estimates were based on testing 100% unresectable stage III-IV melanomas assuming 50% incidence of BRAF mutations. Diagnostic costs were based on reimbursement for average code-stacks across various lab and therapeutic costs for vemurafenib (and ipilimumab) were inclusive of administrative and adverse event costs. Sensitivity models were run to estimate costs across a wide range of values for the various model parameters. Overall, the sum of invalid tests, false positive and false negative results across all 3 studies was 14.6% (148/1014) for Sanger sequencing and 0.6% (6/1014) for the cobas BRAF test. Use of the cobas BRAF test versus Sanger sequencing resulted in total saving of $14.2 million or $1,479.17 per patient in the BRIM-3 study and $21.9 million or $2,281.25 per patient in the BRIM2/3 dataset. Savings were primarily a result of avoiding unnecessary or inappropriate drug therapy and diagnostic costs accounted for a small fraction (0.13-0.29%) of total expenditures. Use of the clinically validated and more accurate cobas BRAF test resulted in significant cost savings relative to Sanger sequencing for BRAF mutations.

Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics?

To investigate which neuropsychological tests predict eventual progression to Alzheimer's disease (AD) in both Hispanic and non-Hispanic individuals. Although our approach was exploratory, we predicted that tests that underestimate cognitive ability in healthy aging Hispanics might not be sensitive to future cognitive decline in this cultural group. We compared first-year data of 22 older adults (11 Hispanic) who were diagnosed as cognitively normal but eventually developed AD (decliners), to 60 age- and education-matched controls (27 Hispanic) who remained cognitively normal. To identify tests that may be culturally biased in our sample, we compared Hispanic with non-Hispanic controls on all tests and asked which tests were sensitive to future decline in each cultural group. Compared to age-, education-, and gender-matched non-Hispanic controls, Hispanic controls obtained lower scores on tests of language, executive function, and some measures of global cognition. Consistent with our predictions, some tests identified non-Hispanic, but not Hispanic, decliners (vocabulary, semantic fluency). Contrary to our predictions, a number of tests on which Hispanics obtained lower scores than non-Hispanics nevertheless predicted eventual progression to AD in both cultural groups (e.g., Boston Naming Test [BNT], Trails A and B). Cross-cultural variation in test sensitivity to decline may reflect greater resistance of medium difficulty items to decline and bilingual advantages that initially protect Hispanics against some aspects of cognitive decline commonly observed in non-Hispanics with preclinical AD. These findings highlight a need for further consideration of cross-cultural differences in neuropsychological test performance and development of culturally unbiased measures.

Mo1178 Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia

Mo1178 Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia

Self-Efficacy Appraisals and Test-Taking Behavior of Students from Culturally Diverse Populations

This study examined the relationships between self-efficacy calibration and test-taking behavior as measured by the percentage of skipped items, unreached items, and incorrect responses on a mathematics test. Jewish and Arab 8th graders in four achievement levels, as defined by quartiles of the test score distribution, were compared with respect to their mathematics self-efficacy and their test-taking behavior. The results indicated that in every achievement level Arab students as compared to their Jewish counterparts tended to report higher levels of self-efficacy and to attempt more items on the test, which resulted in a higher rate of incorrect responses. The results support previous research findings pointing to the detrimental effect that overestimation of SE has on performance. The results were discussed with reference to the metacognitive processes involved in estimation of self-efficacy and in test performance. The identified gaps between the two ethnic groups were discussed in light of the learning culture that characterizes each of them. The contribution of the Israeli context, whereby students from two culturally diverse groups study according to the same mathematics curriculum but in separate schools, to understanding factors underlying culture-related group differences in mathematics test performance was underscored.

Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis

BACKGROUND: Medical imaging techniques are important in the management of many patients with liver disease. Unenhanced ultrasound examinations sometimes identify focal abnormalities in the liver that may require further investigation, primarily to distinguish liver cancers from benign abnormalities. One important factor in selecting an imaging test is the ability to provide a rapid diagnosis. Options for additional imaging investigations include computed tomography (CT) and/or magnetic resonance imaging (MRI) and biopsy when the diagnosis remains uncertain. CT and MRI usually require referral with associated waiting time and are sometimes contraindicated. The use of contrast agents may improve the ability of ultrasound to distinguish between liver cancer and benign abnormalities and, because it can be performed at the same appointment as unenhanced ultrasound, more rapid diagnoses may be possible. OBJECTIVE: To compare the clinical effectiveness and cost-effectiveness of contrast-enhanced ultrasound (CEUS) using SonoVue((R)) with that of contrast-enhanced computed tomography (CECT) and contrast-enhanced magnetic resonance imaging (CEMRI) for the assessment of adults with focal liver lesions (FLLs) in whom previous liver imaging is inconclusive. DATA SOURCES: Eight bibliographic databases including MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and Database of Abstracts of Reviews of Effects were searched from 2000 to September/October 2011. Research registers and conference proceedings were also searched. REVIEW METHODS: Systematic review methods followed published guidance. Risk of bias was assessed using a modified version of the QUADAS-2 tool. Results were stratified by clinical indication for imaging (characterisation of FLLs detected on ultrasound surveillance of cirrhosis patients, detection of liver metastases, characterisation of incidentally detected FLLs, assessment of treatment response). For incidental FLLs, pooled estimates of sensitivity and specificity, with 95% CIs, were calculated using a random-effects model. For other clinical indications a narrative summary was used. The cost-effectiveness of CEUS was modelled separately for the three main clinical applications considered [characterisation of FLLs detected on ultrasound surveillance of cirrhosis patients, detection of liver metastases in patients with colorectal cancer (CRC), characterisation of incidentally detected FLLs]. RESULTS: Of the 854 references identified, 19 (describing 18 studies) were included in the review. Hand searching of conference proceedings identified a further three studies. Twenty of the 21 studies included in the systematic review were diagnostic test accuracy studies. Studies in cirrhosis patients reported varying estimates of test performance. There was no consistent evidence of a significant difference in performance between imaging modalities. It was unclear whether or not CEUS alone is adequate to rule out hepatocellular carcinoma (HCC) for FLLs of < 30 mm; one study indicated that CEUS may be better at ruling out HCC for FLLs of 11-30 mm [very small FLLs (< 10 mm) excluded]. There was no consistent evidence of a difference in test performance between imaging modalities for the detection of metastases; CEUS alone may be adequate to rule out liver metastases in colorectal cancer. In patients with incidentally detected FLLs, the pooled estimates of sensitivity for any malignancy using CEUS and CECT were 95.1% and 94.6%, respectively, and the corresponding specificity estimates were 93.8% and 93.1% respectively. One study comparing CEUS with CEMRI reported similar sensitivity and lower specificity for both modalities. In the surveillance of cirrhosis, CEUS was as effective as but pound379 less costly than CECT. CEMRI was pound1063 more costly than CEUS and gained 0.022 QALYs. In the detection of liver metastases from CRC, CEUS cost pound1 more than CECT, and at a lifetime time horizon they yielded equal QALYs. CEMRI was dominated by CECT. In the characterisation of incidentally detected FLLs, CEUS was slightly more effective than CECT and CEMRI (by 0.0002 QALYs and 0.0026 QALYs respectively) and less costly (by pound52 and pound131 respectively). LIMITATIONS: There were a number of methodological issues specific to the studies included in this review. The main indication for liver imaging in the populations considered is likely to be to rule out primary liver cancer or metastases. Therefore, patient-level analyses of test performance are of particular interest. Some of the studies included in this review reported per-patient analyses; however, no study clearly stated how results were defined (e.g. was the presence of any positive lesion regarded as a positive test for the whole patient). In addition,

Beyond Gender Differences

Proponents of what has been termed the Gender Similarities Hypothesis (GSH) have typically relied on meta-analyses as well as the generation of nonsignificant tests of mean differences to support their argument that the genders are more similar than they are different. In the present article, we argue that alternative statistical methodologies, such as tests of equivalence, can provide more accurate (yet equally rigorous) tests of these hypotheses and therefore might serve to complement, challenge, and/or extend findings from meta-analyses. To demonstrate and test the usefulness of such procedures, we examined Scholastic Aptitude Test–Math (SAT-M) data to determine the degree of similarity between genders in the historically gender-stereotyped field of mathematics. Consistent with previous findings, our results suggest that men and women performed similarly on the SAT-M for every year that we examined (1996–2009). Importantly, our statistical approach provides a greater opportunity to open a dialogue on theoretical issues surrounding what does and what should constitute a meaningful difference in intelligence and achievement. As we note in the discussion, it remains important to consider whether even very small but consistent gender differences in mean test performance could reflect stereotype threat in the testing environment and/or gender biases in the test itself that would be important to address.

COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.

The adverse effects of cannabis use on executive functions are still controversial, fostering the need for novel biomarkers able to unveil individual differences in the cognitive impact of cannabis consumption. Two common genetic polymorphisms have been linked to the neuroadaptive impact of Δ9-tetrahydrocannabinol (THC) exposure and to executive functions in animals: the catechol-O-methyltransferase (COMT) gene val158met polymorphism and the SLC6A4 gene 5-HTTLPR polymorphism. We aimed to test if these polymorphisms moderate the harmful effects of cannabis use on executive function in young cannabis users. We recruited 144 participants: 86 cannabis users and 58 non-drug user controls. Both groups were genotyped and matched for genetic makeup, sex, age, education, and IQ. We used a computerized neuropsychological battery to assess different aspects of executive functions: sustained attention (CANTAB Rapid Visual Information Processing Test, RVIP), working memory (N-back), monitoring/shifting (CANTAB ID/ED set shifting), planning (CANTAB Stockings of Cambridge, SOC), and decision-making (Iowa Gambling Task, IGT). We used general linear model-based analyses to test performance differences between cannabis users and controls as a function of genotypes. We found that: (i) daily cannabis use is not associated with executive function deficits; and (ii) COMT val158met and 5-HTTLPR polymorphisms moderate the link between cannabis use and executive performance. Cannabis users carrying the COMT val/val genotype exhibited lower accuracy of sustained attention, associated with a more strict response bias, than val/val non-users. Cannabis users carrying the COMT val allele also committed more monitoring/shifting errors than cannabis users carrying the met/met genotype. Finally, cannabis users carrying the 5-HTTLPR s/s genotype had worse IGT performance than s/s non-users. COMT and SLC6A4 genes moderate the impact of cannabis use on executive functions.

Physical Characteristics and Abilities of Junior Elite Male and Female Handball Players

This study first aimed to examine strength, speed, and jumping abilities in 29 male and 29 female junior elite handball players and second to compare Under-18 and Under-16 players in the selected parameters. The players were chosen by the Norwegian Handball Federation, and all were tested in strength (squat and bench press), speed (10-, 30-, and 6 × 30-m repeated sprint ability), and jumping abilities (countermovement jump and squat jump [SJ]). Anthropometric qualities were also measured. Independent t-tests were applied to reveal possible mean differences between the U-18 and U-16 players within each sex. No significant differences in anthropometry were observed between the U18 and U16 players within either sex. Furthermore, we did not observe any significant between group differences among the male players in any of the tested performance parameters. On average, however, the U16 male (n = 14) players performed better in all the tests compared with in the U18 (n = 15) male players. Similarly, we did not find any significant differences in test performances between U18 female players and U16 female players. Still, a few trends (p ≤ 0.1) were observed because female U18 (n = 14) players were found to sprint faster on both 10 and 30 m and to jump higher in SJ vs. female U16 (n = 15) players. The empirical findings do not confirm the hypothesis of pubertal development and muscle growth leading to taller and heavier U18 players. Furthermore, we expected U18 players to perform better in all the tests when compared with U16 players. Again, the data did not substantiate this, although female U18 players tended to perform better in sprint and SJ compared with the U16 players.

Examiner Familiarity Effects for Children With Autism Spectrum Disorders

The authors examined the difference in standardized test performance when familiar versus unfamiliar examiners tested 26 preschool and elementary-aged children with autism. The children were matched by age, severity, and developmental level and then randomly placed into familiar and unfamiliar examiner groups. Familiarity with the examiner was established before test administration for children in the treatment group. Both groups were administered 2 subscales of the Psychoeducational Profile-Revised. There was a statistically significant difference in favor of the children tested by the familiar examiners on the cognitive verbal subscale (d = .43) and on the cognitive performance subscale (d = .47), indicating that examiner familiarity had positive effects on the test performance of children with autism. Given these results, it appears that professionals who are responsible for administering standardized tests to children with autism should make pretest contact with these children to reduce test procedure bias.

Differences between Judo, Taekwondo and Kung-fu Athletes in Sustained Attention and Impulse Control

Attention processes are essential in athletic performance. Competition in combat sports requires high levels of attention, concentration and self-control. The aim of this study was to determine the differences in attention test performance among three groups of athletes from different disciplines of martial arts (judo, taekwondo and kung-fu). Twenty athletes with at least one year of experience in their respective sport were included in the study. The Test of Variables of Attention (TOVA) was performed, and data for the standard and Z scores of the quarters, halves and totals of each variable were analysed. The kung-fu athletes showed better inhibition response than the judo and taekwondo athletes. Minor performance deterioration during the impulsivity test was identified in kung-fu athletes compared with taekwondo and judo athletes. Judo athletes showed higher variability in reaction times than kung-fu athletes. Our study suggests that kung-fu training improved attention skills more than the other two disciplines. This effect can be explained by the athletes’ dedication to kung-fu training and the sport’s promotion of discipline, self-control and meditation.

Type-Specific Identification of Anogenital Herpes Simplex Virus Infections by Use of a Commercially Available Nucleic Acid Amplification Test

Herpes infections are among the most common sexually transmitted infections (STI), but diagnostic methods for genital herpes have not kept pace with the movement toward molecular testing. Here, we describe an FDA-approved molecular assay that identifies and types herpes simplex virus (HSV) infections for use in routine clinical settings. Paired samples from anogenital lesions were tested using the BD ProbeTec HSV Q(x) (HSVQ(x)) system, HSV culture and, a laboratory-developed PCR assay. Family planning, obstetrics/gynecology (OB/GYN), or sexually transmitted disease (STD) clinics in the United States served as recruitment sites. Sensitivity and specificity estimates, head-to-head comparisons, measures of agreement, and latent-class analyses were performed to provide robust estimates of performance. A total of 508 participants (174 men and 334 women) with anogenital lesions were included; 260 HSV-2 and 73 HSV-1 infections were identified. No differences in test performance based on gender, clinic type, location of the lesion, or type of lesion were observed. The sensitivity of HSV-2 detection ranged from 98.4 to 100% depending on the analytical approach, while the specificity ranged from 80.6%, compared to the less sensitive culture method, to 97.0%, compared to PCR. For HSV-1, the sensitivity and specificity ranges were 96.7 to 100% and 95.1 to 99.4%, respectively. This assay may improve our ability to accurately diagnose anogenital lesions due to herpes infection.

The effects of low to moderate prenatal alcohol exposure in early pregnancy on IQ in 5-year-old children.

To examine the effects of low to moderate maternal alcohol consumption during early pregnancy on children's intelligence (IQ) at age 5 years. Prospective follow-up study. Neuropsychological testing in four Danish cities 2003-2008. A cohort of 1628 women and their children sampled from the Danish National Birth Cohort. Participants were sampled based on maternal alcohol consumption during pregnancy. At 5 years of age, children were tested with the Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R). Parental education, maternal IQ, maternal smoking in pregnancy, the child's age at testing, gender, and tester were considered core confounding factors, whereas the full model also controlled for maternal binge drinking, age, BMI, parity, home environment, postnatal smoking in the home, health status, and indicators for hearing and vision impairments. The WPPSI-R. No differences in test performance were observed between children whose mothers reported consuming between one and four or between five and eight drinks per week at some point during pregnancy, compared with children of mothers who abstained. For women who reported consuming nine or more drinks per week no differences were observed for mean differences; however, the risks of low full-scale IQ (OR 4.6; 95% CI 1.2-18.2) and low verbal IQ (OR 5.9; 95% CI 1.4-24.9) scores, but not low performance IQ score, were increased. Maternal consumption of low to moderate quantities of alcohol during pregnancy was not associated with the mean IQ score of preschool children. Despite these findings, acceptable levels of alcohol use during pregnancy have not yet been established, and conservative advice for women continues to be to avoid alcohol use during pregnancy.

Neurocognitive Functioning and Symptom Reporting of High School Athletes Following a Single Concussion

The aim of this research was to evaluate the neurocognitive functioning and symptom reporting of high school athletes with the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery after sustaining a single sports-related concussion. The ImPACT battery was administered to 26 athletes at an average of 6.8 days after their head injury. ImPACT composite scores, including neurocognitive measures of Verbal Memory, Visual Memory, Processing Speed, and Reaction Time, as well as a Total Symptom Score, were also obtained from an equivalent group of 25 nonconcussed football players. The composite scores of the concussed athletes were lower but not statistically different than the nonconcussed athletes. The findings were consistent with previous ImPACT research that reported no differences between concussed and nonconcussed athletes 7 days after a concussion. The symptom scores of the concussed athletes, on the other hand, were significantly higher than those who had no concussion. The similarities and differences in ImPACT test performances of the present sample of concussed high school athletes as compared with previous studies of concussed high school athletes are discussed. This study raises awareness that with high school athletes, symptom complaints may persist, even after cognitive functioning has returned to preinjury levels.

Pubertal testosterone predicts mental rotation performance of young adult males

Robust sex differences in some spatial abilities that favor males have raised the question of whether testosterone contributes to those differences. There is some evidence for prenatal organizational effects of testosterone on male-favoring spatial abilities, but not much is known about the role of pubertal testosterone levels on adult cognitive abilities. We studied the association between pubertal testosterone (at age 14) and cognitive performance in young adulthood (at age 21-23), assessing male-favoring, female-favoring, and sex-neutral cognitive domains in a population-based sample of 130 male and 178 female twins. Pubertal testosterone was negatively associated with performance in the Mental Rotation Test in young adult men (r=-.27), while among women no significant associations between testosterone and cognitive measures were detected. The significant association among men remained after controlling for pubertal development. Confirmatory within-family comparisons with one-sided significance testing yielded a negative correlation between twin pair differences in testosterone levels and Mental Rotation Test performances in 35 male twin pairs (r=-.32): the twin brother with higher testosterone performed less well on the Mental Rotation Test. That association was evident in 18 pairs of dizygotic male twin pairs (r=-.42; analysis controlling for shared environmental effects). In contrast, the association of differences was not evident among 17 monozygotic male twin pairs (r=-.07; analysis controlling for shared genetic influences). Results suggest that pubertal testosterone levels are related specifically to male-favoring spatial ability and only among men. Within-family analyses implicated possible shared genetic effects between pubertal testosterone and mental rotation ability.

Revisiting Differential Item Functioning: Implications for Fairness Investigation

Fairness has been the priority in educational assessments during the past few decades. Differential item functioning (DIF) becomes an important statistical procedure in the investigation of assessment fairness. For any given large-scale assessment, DIF evaluation is suggested as a standard procedure by American Educational Research Association, American Psychological Association, and National Council on Measurement in Education. This procedure often affords opportunities to check for group differences in test performance and investigate whether or not these differences indicate bias. However, current DIF research has received several criticisms. Revisiting DIF, this paper critically reviews current DIF research and proposes new directions for DIF research in the investigation of assessment fairness.

International Field Hockey Players Perform More High-Speed Running Than National-Level Counterparts

This study compared the activity profile of national and international male field hockey athletes. Sixteen players (mean (±SD) age, stature, and body mass: 22 ± 4 y, 178 ± 8 cm, and 78 ± 9 kg, respectively) competing in the national-level Australian Hockey League (AHL) and 16 players [mean (±SD) age, stature, and body mass: 27 ± 4 y, 179 ± 5 cm, and 77 ± 5 kg, respectively] competing in the international Champions Trophy (CT) tournament participated in this study. Global positioning systems assessed total distance (TD), meters per minute (m·min(-1)), and high-speed running distance (HSR; >4.17 m·s(-1)). Differences in multistage fitness test performance, movement between competition, positions, and halves were assessed using effect size and percent difference ±90% confidence intervals. The CT players had a 10.1% greater multistage fitness test, 13.9% and 42.0% more TD and HSR, respectively, than AHL. During CT, strikers performed 10.1 ± 7.4% less HSR than midfielders and 26.6 ± 8.2% more HSR than defenders. The AHL defenders covered less TD and HSR distance compared with strikers and midfielders (8.1 ± 3.6% and 8.4 ± 2.6%; 36.1 ± 11.1% and 51.5 ± 12.1%, respectively). The AHL strikers, midfielders, and defenders (19.9 ± 8.8%, 32.1 ± 7.9%, and 30.3 ± 10.7%, respectively), all performed less HSR distance than their CT counterparts. Finally, TD decreased from the first to second halves across all positions (6.1-7.5%) in both competitions. International competition increases the running profile of hockey players, with greater HSR at the elite level and positional differences including decreased running during the second half in both competitions.

Test-Taking Strategy as a Mediator between Race and Academic Performance

The issue of race differences in standardized test scores and academic achievement continues to be a vexing one for behavioral scientists and society at large. Ellis and Ryan (2003) suggested that a portion of the cognitive-ability test performance differences between White/Caucasian-American and Black/African-American college students could be attributed to the greater use of ineffective test-taking strategies by the latter group. We replicated and extended their findings by using three outcomes—exam scores in a single academic course, self-reported GPA, and a measure of verbal abilities. Ellis and Ryan reported that the variance in cognitive-ability test performance explained by race dropped by 48% (i.e., from 21% originally to 11%) when controlling for the mediator, ineffective test-taking strategies. Our results were less dramatic, but also indicated that ineffective test-taking strategies accounted for 19% to 25% of the variance originally explained by race. In addition, reminiscent of the disidentification effect, supplementary analyses showed that academic/intellectual self-perceptions correlated with the criterion measures but only for White participants. These results suggest that a portion of the race difference on test scores might be accounted for by test-taking strategies.

Does student learning style affect performance on different formats of biomechanics examinations?

Students' learning style preferences have been widely adapted into teaching and learning environments. The purpose of this study was to investigate the relationship between self-reported and assessed learning style preferences (visual, auditory, reading/writing, kinesthetic: VARK) on performance in different types of multiple-choice examinations (T1: text only format and T2: visual format) given in an introductory biomechanics class. Students who enrolled in three biomechanics classes at a state university were recruited to participate in the study. Ninety students (47 males and 43 females) completed a learning style survey and two types of examinations. Results showed that approximately half of the students were assessed and self-reported as kinesthetic for their preferred learning style. There was no significant difference in test performance between students who preferred visual and reading/writing learning styles (self-reported and assessed). These students demonstrated similar learning and comprehension of biomechanical concepts regardless of whether the test material was presented in their preferred sensory mode or not. Interestingly, female students' perceptions of their learning style preference may have a positive effect on the test results when the test is presented in their preferred format.